The Clinical Role of N-acetylcysteine in the Management of COPD: A Review of Recent Literature

Publisher: Bentham Science Publishers

E-ISSN: 1875-6387 |12|2|136-141

ISSN: 1573-398x

Source: Current Respiratory Medicine Reviews, Vol.12, Iss.2, 2016-07, pp. : 136-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Currently, bronchodilators are the mainstay treatment of stable chronic obstructivepulmonary disease while systemic corticosteroids and antibiotics have a major role in COPD acuteexacerbations. Inhaled N-acetylcysteine is a mucolytic that has a pharmacologic role in respiratoryconditions associated with excessive thick mucus production. Additionally, N-acetylcysteine hasbeen studied as an adjunct agent for the clinical management of COPD because of its antioxidant andinflammatory properties. This paper provides a narrative review of literature on the effect Nacetylcysteinehas on clinical outcomes in stable COPD and in acute COPD exacerbations. Primaryliterature was sought utilizing databases using Medline (2004-present). The database was searchedusing the key MeSH terms N-acetylcysteine and COPD, COPD exacerbation.lt;/pgt